Bausch Health Companies | Umsatzkosten



Cost Of Sales Veränderung Datum
Amgen USD 3.11B 198M 2024-12
ANI Pharmaceuticals USD 80.28M 68.05M 2024-12
Aurora Cannabis CAD 78.85M 891K 2024-12
Bausch Health Companies USD 696M 23M 2024-09
Biogen USD 583.5M 55.2M 2024-12
Bristol-Myers Squibb USD 3.03B 179M 2025-03
Canopy Growth CAD 50.66M 9.51M 2024-12
Corcept Therapeutics USD 2.96M 89K 2024-12
Danaher USD 2.23B 418M 2025-03
Drreddys Laboratories INR 34.53B 2.14B 2024-12
Eli Lilly USD 2.4B 233M 2024-12
Gilead Sciences USD 1.54B 41M 2025-03
Novo Nordisk 11.31B 1.03B 2024-09
Pacira USD 39.89M 1.02M 2024-12
Perrigo USD 752.4M 69.3M 2024-12
Prestige Brands USD 129.27M 2.86M 2024-12
Supernus Pharmaceuticals USD 17.2M 385K 2024-12
Vertex Pharmaceuticals USD 423.4M 30.8M 2024-12
Zoetis USD 707M 8M 2024-12



Bausch Health Companies Umsatzkosten - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Apr 2025.